The FDA Approval Process Needs Refinement, Not a Total Overhaul
Even though overall drug development times have not changed, questions about the clinical benefit of the drugs that have been approved through expedited pathways are being raised.
Breast Cancer
BREAST CANCER ADVISOR
FEATURED CONTENT
-
-
How Durable Are Responses to Targeted Therapies Across Single-Arm Cancer Trials?
Drugs approved based on changes to surrogate biomarker levels may be subject to measurement bias, according to investigators. -
Reporting Mechanisms for Conflict of Interest Disclosures in Medicine Need Standardization
ASCO officials examined the discrepancies in financial disclosures across platforms and call for a simplified system. -
A First-in-Human Trial Offers Hope for CAR-T in Solid Tumors
CAR-T has seen most of its success in blood cancers, but a first-in-human trial of CAR-T in solid tumors is under way. -
The Cancer Biologics Industry Gets a “Wake-Up Call”: Product Drift Can Occur
A surprising finding led biosimilar manufacturer Samsung Bioepis to investigate trastuzumab, only to discover that lots given to patients had changed.
VIDEO SERIES
The Phase 3 PlanB Trial
Continue to Work?
Drug Resistance to CDK4/6 Inhibitors
Comparing Ribociclib and Palbociclib
Ribociclib, Abemaciclib, and Palbociclib
The Potential of CDK4/6 Inhibitors
How Cyclin D Plays A Role
2016 SABCS: Clinical Insights Telli
2016 SABCS: Clinical Insights Oregan
HER2-positive Metastatic and TNBC
Frontline Treatments
Treatment-related Neuropathy
ER-positive, HER2-negative
Emerging Medicines
Triple-negative Breast Cancer
Insights from the Lab and Clinic
Trastuzumab Resistance
Biologic Role of HER2
Strategies in Management
BREAST CANCER NEWS
Bevacizumab Adoption Tied to Use by Peers
Lack of Insurance Tied to Later Stage of Breast Cancer at Diagnosis
Notification Laws May Not Increase Knowledge of Dense Breast Risks
No Link Found Between Hepatitis C Infection and Extrahepatic Cancers
Cardiac Resynchronization Therapy Associated With Substantial Increase in LVEF in Patients With Chemotherapy-Induced Cardiomyopathy
Want to read more?
Please login or register first to view this content.
Next post in Breast Cancer
